Tiverton, Rhode Island
United States
43
2024-04-25
41
2026-05-05
These are the the leading inventors for applications assigned to VEROSCIENCE LLC:
VEROSCIENCE LLC based in Tiverton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
BROMOCRIPTINE FORMULATIONS
#2 | 2023-10-12 ✅ Patent 12,274,698 granted on 2025-04-15Bromocriptine formulations
#3 | 2023-08-24 ✅ Patent 12,318,451 granted on 2025-06-03Method for inducing tumor regression
#4 | 2023-05-18 ✅ Patent 12,492,198 granted on 2025-12-09Composition and Method for Treating Metabolic Disorders
#5 | 2022-09-15 ✅ Patent 12,357,693 granted on 2025-07-15METHOD FOR INDUCING TUMOR REGRESSION
#6 | 2022-08-25 ✅ Patent 11,883,399 granted on 2024-01-30Bromocriptine formulations
#7 | 2021-07-29 ✅ Patent 11,666,567 granted on 2023-06-06Bromocriptine formulations
#8 | 2021-06-17 ✅ Patent 11,510,921 granted on 2022-11-29Bromocriptine formulations
#9 | 2021-05-06 ✅ Patent 11,878,974 granted on 2024-01-23Composition and method for treating metabolic disorders
#10 | 2021-04-01 ✅ Patent 11,560,375 granted on 2023-01-24Composition and method for treating metabolic disorders
#11 | 2021-03-25 ✅ Patent 11,607,455 granted on 2023-03-21Method for inducing tumor regression
#12 | 2020-09-03 ✅ Patent 11,000,522 granted on 2021-05-11Bromocriptine formulations
#13 | 2020-08-13 ✅ Patent 11,241,429 granted on 2022-02-08Method of treating metabolic disorders and depression with dopamine receptor agonists
#14 | 2019-11-14 ✅ Patent 10,688,094 granted on 2020-06-23Bromocriptine formulations
#15 | 2019-06-06 ✅ Patent 10,675,282 granted on 2020-06-09Method of treating metabolic disorders and depression with dopamine receptor agonists
#16 | 2018-09-20 ✅ Patent 10,307,421 granted on 2019-06-04Bromocriptine formulations
#17 | 2018-05-24 ✅ Patent 10,688,155 granted on 2020-06-23Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#18 | 2018-05-10 ✅ Patent 10,238,653 granted on 2019-03-26Method of treating metabolic disorders and depression with dopamine receptor agonists
#19 | 2018-02-22 ✅ Patent 10,894,791 granted on 2021-01-19Composition and method for treating metabolic disorders
#20 | 2017-11-30 ✅ Patent 9,993,474 granted on 2018-06-12Bromocriptine formulations
#21 | 2017-01-26 ✅ Patent 9,700,555 granted on 2017-07-11Bromocriptine formulations
#22 | 2016-11-10 ✅ Patent 11,045,464 granted on 2021-06-29Parenteral formulations of dopamine agonists
#23 | 2016-09-22 ✅ Patent 9,895,422 granted on 2018-02-20Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#24 | 2016-09-15 ✅ Patent 9,999,653 granted on 2018-06-19Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#25 | 2016-02-11 ✅ Patent 9,522,117 granted on 2016-12-20Bromocriptine formulations
#26 | 2015-11-26 ✅ Patent 9,925,186 granted on 2018-03-27Method of treating metabolic disorders and depression with dopamine receptor agonists
#27 | 2015-01-22 ✅ Patent 9,352,025 granted on 2016-05-31Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#28 | 2014-11-20 ✅ Patent 9,364,515 granted on 2016-06-14Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#29 | 2014-09-04 ✅ Patent 10,137,132 granted on 2018-11-27Parenteral formulations of dopamine agonists
#30 | 2014-07-03 ✅ Patent 9,192,576 granted on 2015-11-24Bromocriptine formulations
#31 | 2014-01-30 ✅ Patent 9,205,084 granted on 2015-12-08Method of treating metabolic disorders and depression with dopamine receptor agonists
#32 | 2013-10-31 ✅ Patent 8,613,947 granted on 2013-12-24Bromocriptine formulations
#33 | 2013-08-01 ✅ Patent 9,415,005 granted on 2016-08-16Parenteral formulations of dopamine agonists
#34 | 2013-04-30 ✅ Patent 8,431,155 granted on 2013-04-30Bromocriptine formulations
#35 | 2012-06-07 ✅ Patent 8,877,708 granted on 2014-11-04Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
#36 | 2012-05-24 ✅ Patent 8,821,915 granted on 2014-09-02Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#37 | 2011-08-11 ✅ Patent 8,137,994 granted on 2012-03-20Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
#38 | 2011-08-11 ✅ Patent 8,137,993 granted on 2012-03-20Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
#39 | 2011-06-09 ✅ Patent 8,137,992 granted on 2012-03-20Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
#40 | 2010-02-11PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS
#41 | 2009-06-04 ✅ Patent 8,741,918 granted on 2014-06-03Parenteral formulations of dopamine agonists
#42 | 2009-05-28METHOD OF TREATING METABOLIC DISORDERS AND DEPRESSION WITH DOPAMINE RECEPTOR AGONISTS
#43 | 2008-11-27 ✅ Patent 9,655,865 granted on 2017-05-23Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
Also check out VeroScience LLC's (Tiverton, United States) applicant profile with 37 patent applications submitted.
32819 ⎘